Description

N-[3-[(3S,3aS,15S)-10,14-Diacetyl-3a,4,6,7,8,9,10,11,12,13,14,15-dodecahydro-15-(2-hydroxyethyl)-3-(4-methoxyphenyl)-4-oxo-1,16-ethenofuro[3,4-l][1,5,10]triazacyclohexadecin-5(3H)-yl]propyl]benzamide is a complex, high-purity synthetic organic compound of significant interest in advanced pharmaceutical research and development. Its intricate polycyclic structure, featuring fused furo-triazacyclohexadecin and benzamide moieties, makes it a valuable intermediate or reference standard for the synthesis of novel bioactive molecules. This compound is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the multi-step synthesis of potential drug candidates, particularly in oncology and complex disease research.
• Reference Standard: Used for analytical method development, validation, and quality control in laboratories to ensure the identity and purity of related compounds.
• Biochemical Research: Employed in academic and industrial research to study structure-activity relationships (SAR) and explore new chemical entities for biological screening.
• Process Chemistry Development: Acts as a key intermediate for scaling up synthetic routes under Good Manufacturing Practice (GMP) conditions for preclinical and clinical trial material production.
• Custom Synthesis: A starting point for the preparation of specialized derivatives and analogs for proprietary research programs.

Basic Information

Product Name	N-[3-[(3S,3aS,15S)-10,14-Diacetyl-3a,4,6,7,8,9,10,11,12,13,14,15-dodecahydro-15-(2-hydroxyethyl)-3-(4-methoxyphenyl)-4-oxo-1,16-ethenofuro[3,4-l][1,5,10]triazacyclohexadecin-5(3H)-yl]propyl]benzamide
CAS No.	69721-76-2
Molecular Formula	C41H48N4O7
Molecular Weight	708.85 g/mol
Synonyms	Benzamide, N-[3-[(3S,3aS,15S)-10,14-diacetyl-3a,4,6,7,8,9,10,11,12,13,14,15-dodecahydro-15-(2-hydroxyethyl)-3-(4-methoxyphenyl)-4-oxo-1,16-ethenofuro[3,4-l][1,5,10]triazacyclohexadecin-5(3H)-yl]propyl]-; 69721-76-2; UNII-8X3R7K6E7F; 8X3R7K6E7F; SCHEMBL23346895; DTXSID701330848; AKOS040757232
EINECS	Contact for details

Quality Control

Our N-[3-[(3S,3aS,15S)-10,14-Diacetyl-3a,4,6,7,8,9,10,11,12,13,14,15-dodecahydro-15-(2-hydroxyethyl)-3-(4-methoxyphenyl)-4-oxo-1,16-ethenofuro[3,4-l][1,5,10]triazacyclohexadecin-5(3H)-yl]propyl]benzamide is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis, to ensure it meets the stringent requirements for research and development use. Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry, well-ventilated area. For long-term storage, consider storing under an inert atmosphere to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.